Patents Assigned to U.S. PHYTOTHERAPY, INC.
  • Alternative ACT with natural botanical active GRAS ingredients for treatment and prevention of the Zika virus
    Patent number: 9675582
    Abstract: An all-natural active ingredient herbal compositions and methods of preparing the same are provided. The novel Artemisinin Combination Therapy (ACT) consists of artemisinin, derivatives of artemisinin, berberine, capsaicin and Tinospora Cordifolia. When formulated in a gel cap, the composition can consist of only artemisinin, berberine, capsaicin, and Tinospora cordifolia. A blended mixture and inert ingredients, such as selected excipient compounds, are mixed together with artemisinin, berberine, capsaicin, and Tinospora cordifolia and compressed to form a single pill, tablet, or capsule for the treatment of Zika virus. A tablet or pill for children is formulated to be chewable.
    Type: Grant
    Filed: May 6, 2016
    Date of Patent: June 13, 2017
    Assignee: U.S. Phytotherapy, Inc.
    Inventor: Bob D. Rosen
  • Additional artemisinin and berberine compositions and methods of making
    Patent number: 9358261
    Abstract: An Alternative ACT composition consisting of natural botanical active ingredients, all of which are GRAS (generally regarded as safe by the FDA). The novel Artemisinin Combination Therapy (ACT) consists of artemisinin and its derivatives, berberine, capsaicin, and papaya extract. The four active substances mixed with various selected excipient compounds to form a single pill, tablet or capsule for the treatment and prevention of chikungunya.
    Type: Grant
    Filed: November 5, 2015
    Date of Patent: June 7, 2016
    Assignee: U.S. Phytotherapy, Inc.
    Inventor: Bob Rosen
  • Artemisinin with berberine compositions and methods of making
    Patent number: 9186331
    Abstract: An all-natural herbal composition and methods of preparing the same are provided. The novel Artemisinin Combination Therapy (ACT) consists of artemisinin and its derivatives and berberine, the two active substances mixed with various selected excipient compounds to form a single pill, tablet or capsule for treatment and prevention of malaria, dengue fever, yellow fever, dysentery, Lyme disease, babesiosis, progressive multifocal leukoencephalopathy, Helicobacter Pylori, and colitis, in adults and children. A tablet or pill for children is formulated to be chewable.
    Type: Grant
    Filed: February 5, 2015
    Date of Patent: November 17, 2015
    Assignee: U.S. Phytotherapy, Inc.
    Inventors: Bob Rosen, Andreas Muehler, Jan Mintorovitch, Karan Arora, David Perez, Nicholas A. Perez, Tejas D. Choksi
  • Artemisinin with berberine compositions and methods of making
    Patent number: 9011892
    Abstract: An all-natural herbal composition and methods of preparing the same are provided. The novel Artemisinin Combination Therapy (ACT) consists of artemisinin and its derivatives and berberine, the two active substances mixed with various selected excipient compounds to form a single pill, tablet or capsule for treatment and prevention of malaria, dengue fever, yellow fever, dysentery, Lyme disease, babesiosis, progressive multifocal leukoencephalopathy, Helicobacter Pylori, and colitis, in adults and children. A tablet or pill for children is formulated to be chewable.
    Type: Grant
    Filed: October 25, 2012
    Date of Patent: April 21, 2015
    Assignee: U.S. Phytotherapy, Inc.
    Inventors: Bob Rosen, Andreas Muehler, Jan Mintorovitch, Karan Arora, David Perez, Nicholas Ari Perez, Tejas D. Choksi
  • Artemisinin with Berberine Compositions and Methods of Making
    Publication number: 20130102625
    Abstract: An all-natural herbal composition and methods of preparing the same are provided. The novel Artemisinin Combination Therapy (ACT) consists of artemisinin and its derivatives and berberine, the two active substances mixed with various selected excipient compounds to form a single pill, tablet or capsule for treatment and prevention of malaria, dengue fever, yellow fever, dysentery, Lyme disease, babesiosis, progressive multifocal leukoencephalopathy, Helicobacter Pylori, and colitis, in adults and children. A tablet or pill for children is formulated to be chewable.
    Type: Application
    Filed: October 25, 2012
    Publication date: April 25, 2013
    Applicant: U.S. PHYTOTHERAPY, INC.
    Inventor: U.S. PHYTOTHERAPY, INC.